Jiangsu Biojetay Biotechnology Co., Ltd.
Clinical trials sponsored by Jiangsu Biojetay Biotechnology Co., Ltd., explained in plain language.
-
New treatment tested for dangerous hemophilia bleeding
Disease control Recruiting nowThis study is testing whether an experimental injection called STSP-0601 can safely and effectively stop bleeding episodes in people with hemophilia A or B who have developed inhibitors. The trial will enroll 32 adults who experience frequent bleeding episodes to see how well the…
Phase: PHASE3 • Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New shot tested to boost platelets in blood disorder
Disease control Recruiting nowThis study is testing a new injectable drug called STSA-1301 for people with a chronic immune disorder that causes low platelet counts (ITP). The main goals are to check if the drug is safe and to see if it can help raise and maintain platelet levels. It will involve both healthy…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC